Search Results - "Abrahamsson, P A"

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel by Aapro, M., Abrahamsson, P.A., Body, J.J., Coleman, R.E., Colomer, R., Costa, L., Crinò, L., Dirix, L., Gnant, M., Gralow, J., Hadji, P., Hortobagyi, G.N., Jonat, W., Lipton, A., Monnier, A., Paterson, A.H.G., Rizzoli, R., Saad, F., Thürlimann, B.

“…Bisphosphonates (BP) prevent, reduce, and delay cancer-related skeletal complications in patients, and have substantially decreased the prevalence of such…”
Get full text

New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists by Shore, N D, Abrahamsson, P-A, Anderson, J, Crawford, E D, Lange, P

“…Androgen deprivation therapy (ADT) is first-line treatment for metastatic prostate cancer (PCa). Gonadotrophin-releasing hormone (GnRH) agonists are the most…”
Get full text

Neuroendocrine cells in tumour growth of the prostate by Abrahamsson, P A

“…The prognostic significance of neuroendocrine differentiation in prostatic malignancy is controversial, but the results of recent studies with markers such as…”
Get full text

Three‐month neoadjuvant hormonal therapy before radical prostatectomy: a 7‐year follow‐up of a randomized controlled trial by Aus, G., Abrahamsson, P.‐A., Ahlgren, G., Hugosson, J., Lundberg, S., Schain, M., Schelin, S., Pedersen, K.

“…Objective  To describe the outcome, assessed as the level of prostate specific antigen (PSA), of a mature (more than half the events recorded) prospective…”
Get full text

Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines by Dizeyi, N., Bjartell, A., Nilsson, E., Hansson, J., Gadaleanu, V., Cross, N., Abrahamsson, P.-A.

“…BACKGROUND Increase in the number of serotonin (5‐HT) releasing neuroendocrine (NE) cells has been shown to be correlated with tumor progression, loss of…”
Get full text

Clinical trial update and novel therapeutic approaches for metastatic prostate cancer by Larsson, R, Mongan, N P, Johansson, M, Shcherbina, L, Abrahamsson, P-A, Gudas, L J, Sterner, O, Persson, J L

“…Recurrent prostate cancer (PCa) remains a major clinical challenge. Invasive and metastatic PCa lesions often exhibit a partial and time-limited response to…”
Get more information

AKT and AMPK activation after high-fat and high-glucose in vitro treatment of prostate epithelial cells by Ribeiro, D L, Góes, R M, Pinto-Fochi, M E, Taboga, S R, Abrahamsson, P-A, Dizeyi, N

“…Considering the increasing consumption of saturated fat and glucose in diets worldwide and its possible association to carcinogenesis, this investigation…”
Get more information

Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals of Oncology 25(1): 9–15, 2014) by Valentini, V., Abrahamsson, P.-A., Aranda, S.K., Astier, A., Audisio, R.A., Boniol, M., Bonomo, L., Brunelli, A., Bultz, B., Chiti, A., De Lorenzo, F., Eriksen, J.G., Goh, V., Gospodarowicz, M.K., Grassi, L., Kelly, J., Kortmann, R.D., Kutluk, T., Plate, A., Poston, G., Saarto, T., Soffietti, R., Torresin, A., van Harten, W.H., Verzijlbergen, J.F., von Kalle, C., Poortmans, P.

Get full text

Neuroendocrine differentiation in prostatic carcinoma by Abrahamsson, Per-Anders

“…BACKGROUND Information is presented on prostatic neuroendocrine cells and neuroendocrine differentiation in prostatic carcinoma. The prognostic and therapeutic…”
Get full text

Expression of Serotonin Receptors 2B and 4 in Human Prostate Cancer Tissue and Effects of Their Antagonists on Prostate Cancer Cell Lines by Dizeyi, N., Bjartell, A., Hedlund, P., Taskén, K.A., Gadaleanu, V., Abrahamsson, P-A.

“…Overexpression of receptors to neuroendocrine (NE) cell products has been suggested to contribute to development of hormone-refractory prostate cancer (HRPC)…”
Get full text

Neuroendocrine pathogenesis in adenocarcinoma of the prostate by Hansson, J., Abrahamsson, P.-A.

“…In the prostate, the importance of sex hormones for its normal development and function is well known. However, it has been proposed that various…”
Get full text

Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment by Ahlgren, G., Pedersen, K., Lundberg, S., Aus, G., Hugosson, J., Abrahamsson, P.-A.

“…BACKGROUND We studied the extent of neuroendocrine (NE) tumor cell differentiation and its relation to regressive changes in prostate cancer after 3‐month…”
Get full text

No association between mutations in the human androgen receptor GGN repeat and inter‐sex conditions by Lundin, K.B., Giwercman, A., Richthoff, J., Abrahamsson, P‐A., Giwercman, Y.L.

“…The functional role of the GGN repeat in the human androgen receptor gene is unknown, although mutations in this region have been found in patients with…”
Get full text

Risks and Benefits of Hormonal Manipulation as Monotherapy or Adjuvant Treatment in Localised Prostate Cancer by Abrahamsson, P.-A., Anderson, J., Boccon-Gibod, L., Schulman, C., Studer, U.E., Wirth, M.

“…A round table meeting was held to discuss the role of hormonal therapy in localised prostate cancer. The findings of the group were that immediate hormonal…”
Get full text

Neuroendocrine Differentiation in Prostatic Carcinoma During Hormonal Treatment by Jiborn, Thomas, Bjartell, Anders, Abrahamsson, Per-Anders

“…Objectives. Neuroendocrine differentiation (NED) is a common feature in adenocarcinoma of the prostate. Several studies suggest that NED may have a major…”
Get full text

Treatment of locally advanced prostate cancer--a new role for antiandrogen monotherapy? by Abrahamsson, P A

“…Men with locally advanced prostate cancer face a high risk of disease progression and cancer-related death. The traditional active treatment options for…”
Get more information

PSA-PFS in metastatic or high risk prostate cancer patients treated with GnRH antagonist (degarelix) versus LHRH agonists – A pooled analysis of data from the Americas, Europe and Asia by Shore, N., Bosnyak, Z., Gittelman, M., Malmberg, A., Abrahamsson, P.-A., Xie, L.-P.

Get full text

Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios by Oesterling, J E, Jacobsen, S J, Klee, G G, Pettersson, K, Piironen, T, Abrahamsson, P A, Stenman, U H, Dowell, B, Lövgren, T, Lilja, H

“…Prostate specific antigen (PSA) exists in the serum in several molecular forms that can be measured by immunodetectable assays: free PSA, PSA complexed to…”
Get more information

Semenogelin, the predominant protein in human semen. Primary structure and identification of closely related proteins in the male accessory sex glands and on the spermatozoa by Lilja, H, Abrahamsson, P A, Lundwall, A

“…The predominant protein in human semen, semenogelin, was characterized by lambda gt11 clones isolated from a seminal vesicular cDNA library. One clone,…”
Get full text

Octreotide scintigraphy and Chromogranin A do not predict clinical response in patients with octreotide acetate-treated hormone-refractory prostate cancer by Kalkner, K M, Acosta, S, Thorsson, O, Frederiksen, H, Nilsson, A, Gustavsson, B, Elingsbo, M, Stridsberg, M, Abrahamsson, P-A

“…In this pilot study, the predictive value of Octreotide scintigraphy (Octreoscan) and/or Chromogranin-A (CgA) was investigated in patients with…”
Get full text